MENU
NUVL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nuvalent (NUVL) Earnings Date & Reports
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more
A.I. Advisor
published Earnings
NUVL is expected to report earnings to rise 1.44% to -140 cents per share on August 06
Q2'26
Est.
$-1.41
Q1'26
Missed
by $0.04
Q4'25
Missed
by $0.10
Q3'25
Missed
by $0.34
Q2'25
Missed
by $0.17
The last earnings report on May 07 showed earnings per share of -138 cents, missing the estimate of -135 cents. With 557.40K shares outstanding, the current market capitalization sits at 9.76B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
One Broadway
Phone
+1 857 357-7000
Employees
228
Web
https://www.nuvalent.com